Drug company AstraZeneca and researchers at Oxford University have hit pause on the trial of their coronavirus vaccine. Regulators say they’re reviewing safety data after adverse reactions in one participant in the vaccine’s phase three trial. Ian Jones is a professor of virology at the University of Reading in the UK, and explains what this means to host Marco Werman.
The article you just read is free because dedicated readers and listeners like you chose to support our nonprofit newsroom. Our team works tirelessly to ensure you hear the latest in international, human-centered reporting every weekday. But our work would not be possible without you. We need your help.
Make a gift today to help us reach our $25,000 goal and keep The World going strong. Every gift will get us one step closer.